6XC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Soleno Therapeutics Inc

Watchlist Manager

Watchlist

Price: 44.86 EUR Market Closed

Market Cap: €1.7B

	Soleno Therapeutics Inc F:6XC	US
S	Schlumberger NV BMV:SLBN	US
	Koninklijke Philips NV F:PHI1	NL
A	AP Moeller - Maersk A/S XMUN:DP4B	DK
A	Apple Inc F:APC	US
P	Petroleo Brasileiro SA Petrobras BCBA:APBRA	BR
	Reitmans Canada Ltd F:CX40	CA
D	DRDGOLD Ltd JSE:DRD	ZA
M	Metro AG DUS:B4B	DE

Profitability Summary

Soleno Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

98%

Exceptional Operating Margin

30%

Negative 3Y Average Operating Margin

-160%

Exceptional Net Margin

34%

Negative 3Y Average Net Margin

-147%

Exceptional Free Cash Flow Margin

37%

Negative 3Y Average Free Cash Flow Margin

-56%

Exceptional ROE

26%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-475%

ROIC is Increasing

-313% > 46%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.